Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1387508 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,250,383
+$582,687 QoQ
Shares Held
154,970
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#190
of 671 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2021
CallValue
$0
CallShares
0
PutValue
$2,871,000
PutShares
290,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (25.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page
154,970 $5,250,383

All Filings in TEVA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,250,383 154,970
2026-03-31 $4,667,696 154,970
2025-12-31 $3,166,878 101,470
2025-09-30 $3,098,437 153,388
2025-06-30 $2,573,414 153,545
2025-03-31 $677,509 44,080
2024-12-31 $455,787 20,680
2024-09-30 $299,582 16,625
2024-06-30 $266,857 16,422
2024-03-31 $230,388 16,328
2021-06-30 $2,871,000 290,000
2020-09-30 $16,614 1,844
2020-06-30 $1,233 100
2020-03-31 $26,940 3,000
2020-03-31 $30,532 3,400